Study of STG-001 in Subjects With Stargardt Disease
Clinical trial NCT04489511 · COMPLETED
Trial details
- NCT number
- NCT04489511
- Sponsor
- Stargazer Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2021-04-24
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.